New From CBO

Status of CBO’s cost estimate for S. 2543, the Prescription Drug Pricing Reduction Act of 2019
Congressional Proposals Related to a Lapse in Appropriations

Status of CBO’s cost estimate for S. 2543, the Prescription Drug Pricing Reduction Act of 2019

Letter to the Honorable Chuck Grassley

• Email to a friend •

Congressional Proposals Related to a Lapse in Appropriations

Presentation by Justin Riordan, an analyst in CBO’s Budget Analysis Division, at the annual conference of the Association for Budgeting and Financial Management.

• Email to a friend •